TY  - GEN
AU  - Small,Trudy N
AU  - Young,James W
AU  - Castro-Malaspina,Hugo
AU  - Prockop,Susan
AU  - Wilton,Andrew
AU  - Heller,Glenn
AU  - Boulad,Farid
AU  - Chiu,Michelle
AU  - Hsu,Katherine
AU  - Jakubowski,Ann
AU  - Kernan,Nancy A
AU  - Perales,Miguel-Angel
AU  - O'Reilly,Richard J
AU  - Papadopoulos,Esperanza B
TI  - Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies
SN  - 1083-8791
PY  - 2007///0313
KW  - Adolescent
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Busulfan
KW  - administration & dosage
KW  - Child
KW  - Child, Preschool
KW  - Female
KW  - Hematopoietic Stem Cell Transplantation
KW  - Histocompatibility Testing
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Infant
KW  - Leukemia, Myeloid, Acute
KW  - therapy
KW  - Male
KW  - Melphalan
KW  - Methotrexate
KW  - Middle Aged
KW  - Myelodysplastic Syndromes
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Prospective Studies
KW  - Survival Analysis
KW  - Tacrolimus
KW  - Transplantation Conditioning
KW  - methods
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1016/j.bbmt.2006.10.005
ER  -